FilingReader Intelligence
Jinyu Bio-Technology gets China's first FIP mRNA vaccine trial approval
July 26, 2025 at 05:00 AM UTC•By FilingReader AI
Jinyu Bio-Technology announced its subsidiary Jinyu Baoling Biological Products received clinical trial approval from the Ministry of Agriculture and Rural Affairs for a feline infectious peritonitis mRNA vaccine.
This marks the first time a Chinese company has obtained clinical trial approval for a veterinary nucleic acid vaccine against the highly fatal feline disease. Total research and development investment reached approximately 6.2 million yuan.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Jinyu Bio-Technology publishes news
Free account required • Unsubscribe anytime